C the Signs
Healthcare AI
cancer detection / clinical decision support
Seed
C the Signs is an AI-powered clinical platform that helps healthcare professionals identify patients at risk of cancer at the earliest and most treatable stage by analyzing electronic health records, signs, symptoms, risk factors, and evidence-based data to recommend the right diagnostic pathway quickly. It is positioned as an MHRA Class I medical device and is integrated with primary care systems, with a focus on early cancer detection across 100+ cancer types.
Company Details
- Website
- cthesigns.com
- Headquarters
- London, United Kingdom
- Founded
- 2017
- Funding
- $8M+
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring